4893
Noile-Immune Biotech Inc.
Related News
Timely Disclosures
Securities Reports
Earnings Trend
Screening
Compare
Economic Calendar
We use cookies in accordance with European GDPR standards to improve site usability, analytics, and deliver personalized advertising.Learn moreCookie Settings
Noile-Immune Biotech (4893) has released its financial results, reporting an operating loss of 419 million yen, an ordinary loss of 370 million yen, and a net loss of 372 million yen, with a net loss
